- Clinical Trials
- July 2024
- 102 Pages
Global
From €3075EUR$3,450USD£2,660GBP
- Clinical Trials
- July 2024
- 458 Pages
Global
From €3075EUR$3,450USD£2,660GBP
- Clinical Trials
- July 2024
- 488 Pages
Global
From €3075EUR$3,450USD£2,660GBP
- Report
- July 2024
- 48 Pages
Global
From €3561EUR$3,995USD£3,081GBP
- Report
- July 2024
- 65 Pages
Global
From €3115EUR$3,495USD£2,695GBP
- Report
- July 2024
- 69 Pages
Global
From €3115EUR$3,495USD£2,695GBP
- Report
- July 2024
- 66 Pages
Global
From €3115EUR$3,495USD£2,695GBP
- Report
- June 2024
- 65 Pages
Global
From €3115EUR$3,495USD£2,695GBP
- Report
- June 2024
- 63 Pages
Global
From €3115EUR$3,495USD£2,695GBP
- Report
- May 2024
- 128 Pages
Global
From €3565EUR$4,000USD£3,085GBP
- Report
- April 2024
- 45 Pages
Global
From €8909EUR$9,995USD£7,708GBP
- Report
- March 2024
- 115 Pages
Global
From €3565EUR$4,000USD£3,085GBP
- Report
- December 2023
- 117 Pages
Global
From €13365EUR$14,995USD£11,563GBP
- Report
- December 2023
- 115 Pages
Global
From €13365EUR$14,995USD£11,563GBP
- Report
- December 2023
- 62 Pages
Global
From €8909EUR$9,995USD£7,708GBP
- Report
- December 2023
- 91 Pages
Global
From €3115EUR$3,495USD£2,695GBP
- Clinical Trials
- December 2023
- 299 Pages
Global
From €2228EUR$2,500USD£1,928GBP
- Clinical Trials
- December 2023
- 2092 Pages
Global
From €2228EUR$2,500USD£1,928GBP
- Report
- December 2023
- 67 Pages
Global
From €8909EUR$9,995USD£7,708GBP
- Report
- December 2023
- 59 Pages
Global
From €8909EUR$9,995USD£7,708GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more